Global Acute Myeloid Leukemia Market Research Report 2023

Report ID: 1989409 | Published Date: Jan 2025 | No. of Page: 86 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Acute Myeloid Leukemia Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Chemotherapy
        1.2.3 Radiation Therapy
        1.2.4 Stem Cell Transplant
        1.2.5 Targeted Therapy
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Acute Myeloid Leukemia Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Retails Drug Stores
        1.3.4 Ambulatory Care Centers
        1.3.5 Oncology Centers
        1.3.6 Clinics
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Acute Myeloid Leukemia Market Perspective (2017-2028)
    2.2 Acute Myeloid Leukemia Growth Trends by Region
        2.2.1 Acute Myeloid Leukemia Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Acute Myeloid Leukemia Historic Market Size by Region (2017-2022)
        2.2.3 Acute Myeloid Leukemia Forecasted Market Size by Region (2023-2028)
    2.3 Acute Myeloid Leukemia Market Dynamics
        2.3.1 Acute Myeloid Leukemia Industry Trends
        2.3.2 Acute Myeloid Leukemia Market Drivers
        2.3.3 Acute Myeloid Leukemia Market Challenges
        2.3.4 Acute Myeloid Leukemia Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Acute Myeloid Leukemia Players by Revenue
        3.1.1 Global Top Acute Myeloid Leukemia Players by Revenue (2017-2022)
        3.1.2 Global Acute Myeloid Leukemia Revenue Market Share by Players (2017-2022)
    3.2 Global Acute Myeloid Leukemia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Acute Myeloid Leukemia Revenue
    3.4 Global Acute Myeloid Leukemia Market Concentration Ratio
        3.4.1 Global Acute Myeloid Leukemia Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Acute Myeloid Leukemia Revenue in 2021
    3.5 Acute Myeloid Leukemia Key Players Head office and Area Served
    3.6 Key Players Acute Myeloid Leukemia Product Solution and Service
    3.7 Date of Enter into Acute Myeloid Leukemia Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Acute Myeloid Leukemia Breakdown Data by Type
    4.1 Global Acute Myeloid Leukemia Historic Market Size by Type (2017-2022)
    4.2 Global Acute Myeloid Leukemia Forecasted Market Size by Type (2023-2028)
5 Acute Myeloid Leukemia Breakdown Data by Application
    5.1 Global Acute Myeloid Leukemia Historic Market Size by Application (2017-2022)
    5.2 Global Acute Myeloid Leukemia Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Acute Myeloid Leukemia Market Size (2017-2028)
    6.2 North America Acute Myeloid Leukemia Market Size by Country (2017-2022)
    6.3 North America Acute Myeloid Leukemia Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Acute Myeloid Leukemia Market Size (2017-2028)
    7.2 Europe Acute Myeloid Leukemia Market Size by Country (2017-2022)
    7.3 Europe Acute Myeloid Leukemia Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Acute Myeloid Leukemia Market Size (2017-2028)
    8.2 Asia-Pacific Acute Myeloid Leukemia Market Size by Country (2017-2022)
    8.3 Asia-Pacific Acute Myeloid Leukemia Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Acute Myeloid Leukemia Market Size (2017-2028)
    9.2 Latin America Acute Myeloid Leukemia Market Size by Country (2017-2022)
    9.3 Latin America Acute Myeloid Leukemia Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Acute Myeloid Leukemia Market Size (2017-2028)
    10.2 Middle East & Africa Acute Myeloid Leukemia Market Size by Country (2017-2022)
    10.3 Middle East & Africa Acute Myeloid Leukemia Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Celgene Corporation
        11.1.1 Celgene Corporation Company Detail
        11.1.2 Celgene Corporation Business Overview
        11.1.3 Celgene Corporation Acute Myeloid Leukemia Introduction
        11.1.4 Celgene Corporation Revenue in Acute Myeloid Leukemia Business (2017-2022)
        11.1.5 Celgene Corporation Recent Development
    11.2 Cephalon
        11.2.1 Cephalon Company Detail
        11.2.2 Cephalon Business Overview
        11.2.3 Cephalon Acute Myeloid Leukemia Introduction
        11.2.4 Cephalon Revenue in Acute Myeloid Leukemia Business (2017-2022)
        11.2.5 Cephalon Recent Development
    11.3 Clavis Pharma
        11.3.1 Clavis Pharma Company Detail
        11.3.2 Clavis Pharma Business Overview
        11.3.3 Clavis Pharma Acute Myeloid Leukemia Introduction
        11.3.4 Clavis Pharma Revenue in Acute Myeloid Leukemia Business (2017-2022)
        11.3.5 Clavis Pharma Recent Development
    11.4 Eisai
        11.4.1 Eisai Company Detail
        11.4.2 Eisai Business Overview
        11.4.3 Eisai Acute Myeloid Leukemia Introduction
        11.4.4 Eisai Revenue in Acute Myeloid Leukemia Business (2017-2022)
        11.4.5 Eisai Recent Development
    11.5 Genzyme Corporation
        11.5.1 Genzyme Corporation Company Detail
        11.5.2 Genzyme Corporation Business Overview
        11.5.3 Genzyme Corporation Acute Myeloid Leukemia Introduction
        11.5.4 Genzyme Corporation Revenue in Acute Myeloid Leukemia Business (2017-2022)
        11.5.5 Genzyme Corporation Recent Development
    11.6 Sunesis Pharmaceuticals
        11.6.1 Sunesis Pharmaceuticals Company Detail
        11.6.2 Sunesis Pharmaceuticals Business Overview
        11.6.3 Sunesis Pharmaceuticals Acute Myeloid Leukemia Introduction
        11.6.4 Sunesis Pharmaceuticals Revenue in Acute Myeloid Leukemia Business (2017-2022)
        11.6.5 Sunesis Pharmaceuticals Recent Development
    11.7 Abbvie
        11.7.1 Abbvie Company Detail
        11.7.2 Abbvie Business Overview
        11.7.3 Abbvie Acute Myeloid Leukemia Introduction
        11.7.4 Abbvie Revenue in Acute Myeloid Leukemia Business (2017-2022)
        11.7.5 Abbvie Recent Development
    11.8 Astellas Pharma
        11.8.1 Astellas Pharma Company Detail
        11.8.2 Astellas Pharma Business Overview
        11.8.3 Astellas Pharma Acute Myeloid Leukemia Introduction
        11.8.4 Astellas Pharma Revenue in Acute Myeloid Leukemia Business (2017-2022)
        11.8.5 Astellas Pharma Recent Development
    11.9 CTI Biopharma Corp
        11.9.1 CTI Biopharma Corp Company Detail
        11.9.2 CTI Biopharma Corp Business Overview
        11.9.3 CTI Biopharma Corp Acute Myeloid Leukemia Introduction
        11.9.4 CTI Biopharma Corp Revenue in Acute Myeloid Leukemia Business (2017-2022)
        11.9.5 CTI Biopharma Corp Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Acute Myeloid Leukemia Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Chemotherapy
    Table 3. Key Players of Radiation Therapy
    Table 4. Key Players of Stem Cell Transplant
    Table 5. Key Players of Targeted Therapy
    Table 6. Key Players of Others
    Table 7. Global Acute Myeloid Leukemia Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Acute Myeloid Leukemia Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Acute Myeloid Leukemia Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Acute Myeloid Leukemia Market Share by Region (2017-2022)
    Table 11. Global Acute Myeloid Leukemia Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Acute Myeloid Leukemia Market Share by Region (2023-2028)
    Table 13. Acute Myeloid Leukemia Market Trends
    Table 14. Acute Myeloid Leukemia Market Drivers
    Table 15. Acute Myeloid Leukemia Market Challenges
    Table 16. Acute Myeloid Leukemia Market Restraints
    Table 17. Global Acute Myeloid Leukemia Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Acute Myeloid Leukemia Market Share by Players (2017-2022)
    Table 19. Global Top Acute Myeloid Leukemia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Myeloid Leukemia as of 2021)
    Table 20. Ranking of Global Top Acute Myeloid Leukemia Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Acute Myeloid Leukemia Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Acute Myeloid Leukemia Product Solution and Service
    Table 24. Date of Enter into Acute Myeloid Leukemia Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Acute Myeloid Leukemia Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Acute Myeloid Leukemia Revenue Market Share by Type (2017-2022)
    Table 28. Global Acute Myeloid Leukemia Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Acute Myeloid Leukemia Revenue Market Share by Type (2023-2028)
    Table 30. Global Acute Myeloid Leukemia Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Acute Myeloid Leukemia Revenue Market Share by Application (2017-2022)
    Table 32. Global Acute Myeloid Leukemia Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Acute Myeloid Leukemia Revenue Market Share by Application (2023-2028)
    Table 34. North America Acute Myeloid Leukemia Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Acute Myeloid Leukemia Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Acute Myeloid Leukemia Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Acute Myeloid Leukemia Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Acute Myeloid Leukemia Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Acute Myeloid Leukemia Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Acute Myeloid Leukemia Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Acute Myeloid Leukemia Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Acute Myeloid Leukemia Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Acute Myeloid Leukemia Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Celgene Corporation Company Detail
    Table 45. Celgene Corporation Business Overview
    Table 46. Celgene Corporation Acute Myeloid Leukemia Product
    Table 47. Celgene Corporation Revenue in Acute Myeloid Leukemia Business (2017-2022) & (US$ Million)
    Table 48. Celgene Corporation Recent Development
    Table 49. Cephalon Company Detail
    Table 50. Cephalon Business Overview
    Table 51. Cephalon Acute Myeloid Leukemia Product
    Table 52. Cephalon Revenue in Acute Myeloid Leukemia Business (2017-2022) & (US$ Million)
    Table 53. Cephalon Recent Development
    Table 54. Clavis Pharma Company Detail
    Table 55. Clavis Pharma Business Overview
    Table 56. Clavis Pharma Acute Myeloid Leukemia Product
    Table 57. Clavis Pharma Revenue in Acute Myeloid Leukemia Business (2017-2022) & (US$ Million)
    Table 58. Clavis Pharma Recent Development
    Table 59. Eisai Company Detail
    Table 60. Eisai Business Overview
    Table 61. Eisai Acute Myeloid Leukemia Product
    Table 62. Eisai Revenue in Acute Myeloid Leukemia Business (2017-2022) & (US$ Million)
    Table 63. Eisai Recent Development
    Table 64. Genzyme Corporation Company Detail
    Table 65. Genzyme Corporation Business Overview
    Table 66. Genzyme Corporation Acute Myeloid Leukemia Product
    Table 67. Genzyme Corporation Revenue in Acute Myeloid Leukemia Business (2017-2022) & (US$ Million)
    Table 68. Genzyme Corporation Recent Development
    Table 69. Sunesis Pharmaceuticals Company Detail
    Table 70. Sunesis Pharmaceuticals Business Overview
    Table 71. Sunesis Pharmaceuticals Acute Myeloid Leukemia Product
    Table 72. Sunesis Pharmaceuticals Revenue in Acute Myeloid Leukemia Business (2017-2022) & (US$ Million)
    Table 73. Sunesis Pharmaceuticals Recent Development
    Table 74. Abbvie Company Detail
    Table 75. Abbvie Business Overview
    Table 76. Abbvie Acute Myeloid Leukemia Product
    Table 77. Abbvie Revenue in Acute Myeloid Leukemia Business (2017-2022) & (US$ Million)
    Table 78. Abbvie Recent Development
    Table 79. Astellas Pharma Company Detail
    Table 80. Astellas Pharma Business Overview
    Table 81. Astellas Pharma Acute Myeloid Leukemia Product
    Table 82. Astellas Pharma Revenue in Acute Myeloid Leukemia Business (2017-2022) & (US$ Million)
    Table 83. Astellas Pharma Recent Development
    Table 84. CTI Biopharma Corp Company Detail
    Table 85. CTI Biopharma Corp Business Overview
    Table 86. CTI Biopharma Corp Acute Myeloid Leukemia Product
    Table 87. CTI Biopharma Corp Revenue in Acute Myeloid Leukemia Business (2017-2022) & (US$ Million)
    Table 88. CTI Biopharma Corp Recent Development
    Table 89. Research Programs/Design for This Report
    Table 90. Key Data Information from Secondary Sources
    Table 91. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Acute Myeloid Leukemia Market Share by Type: 2021 VS 2028
    Figure 2. Chemotherapy Features
    Figure 3. Radiation Therapy Features
    Figure 4. Stem Cell Transplant Features
    Figure 5. Targeted Therapy Features
    Figure 6. Others Features
    Figure 7. Global Acute Myeloid Leukemia Market Share by Application in 2021 & 2028
    Figure 8. Hospital Case Studies
    Figure 9. Retails Drug Stores Case Studies
    Figure 10. Ambulatory Care Centers Case Studies
    Figure 11. Oncology Centers Case Studies
    Figure 12. Clinics Case Studies
    Figure 13. Acute Myeloid Leukemia Report Years Considered
    Figure 14. Global Acute Myeloid Leukemia Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 15. Global Acute Myeloid Leukemia Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Acute Myeloid Leukemia Market Share by Region: 2021 VS 2028
    Figure 17. Global Acute Myeloid Leukemia Market Share by Players in 2021
    Figure 18. Global Top Acute Myeloid Leukemia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Myeloid Leukemia as of 2021)
    Figure 19. The Top 10 and 5 Players Market Share by Acute Myeloid Leukemia Revenue in 2021
    Figure 20. North America Acute Myeloid Leukemia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. North America Acute Myeloid Leukemia Market Share by Country (2017-2028)
    Figure 22. United States Acute Myeloid Leukemia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada Acute Myeloid Leukemia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Acute Myeloid Leukemia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe Acute Myeloid Leukemia Market Share by Country (2017-2028)
    Figure 26. Germany Acute Myeloid Leukemia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Acute Myeloid Leukemia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Acute Myeloid Leukemia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Acute Myeloid Leukemia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Acute Myeloid Leukemia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Acute Myeloid Leukemia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Acute Myeloid Leukemia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Acute Myeloid Leukemia Market Share by Region (2017-2028)
    Figure 34. China Acute Myeloid Leukemia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Japan Acute Myeloid Leukemia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. South Korea Acute Myeloid Leukemia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Southeast Asia Acute Myeloid Leukemia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. India Acute Myeloid Leukemia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Australia Acute Myeloid Leukemia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Acute Myeloid Leukemia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Latin America Acute Myeloid Leukemia Market Share by Country (2017-2028)
    Figure 42. Mexico Acute Myeloid Leukemia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Brazil Acute Myeloid Leukemia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa Acute Myeloid Leukemia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Middle East & Africa Acute Myeloid Leukemia Market Share by Country (2017-2028)
    Figure 46. Turkey Acute Myeloid Leukemia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Saudi Arabia Acute Myeloid Leukemia Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Celgene Corporation Revenue Growth Rate in Acute Myeloid Leukemia Business (2017-2022)
    Figure 49. Cephalon Revenue Growth Rate in Acute Myeloid Leukemia Business (2017-2022)
    Figure 50. Clavis Pharma Revenue Growth Rate in Acute Myeloid Leukemia Business (2017-2022)
    Figure 51. Eisai Revenue Growth Rate in Acute Myeloid Leukemia Business (2017-2022)
    Figure 52. Genzyme Corporation Revenue Growth Rate in Acute Myeloid Leukemia Business (2017-2022)
    Figure 53. Sunesis Pharmaceuticals Revenue Growth Rate in Acute Myeloid Leukemia Business (2017-2022)
    Figure 54. Abbvie Revenue Growth Rate in Acute Myeloid Leukemia Business (2017-2022)
    Figure 55. Astellas Pharma Revenue Growth Rate in Acute Myeloid Leukemia Business (2017-2022)
    Figure 56. CTI Biopharma Corp Revenue Growth Rate in Acute Myeloid Leukemia Business (2017-2022)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Celgene Corporation
Cephalon
Clavis Pharma
Eisai
Genzyme Corporation
Sunesis Pharmaceuticals
Abbvie
Astellas Pharma
CTI Biopharma Corp
Frequently Asked Questions
Acute Myeloid Leukemia report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Acute Myeloid Leukemia report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Acute Myeloid Leukemia report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports